A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease.

drug protocol number
H7T-MC-TADO
drug sponsor
Eli Lilly
drug study
Prasugrel
drug trial site
KAUH-J
drug status
Terminated
drug phase